News & Views | Published:

HIV

Early treatment may not be early enough

Nature volume 512, pages 3536 (07 August 2014) | Download Citation

Giving monkeys antiretroviral therapy from just three days after exposure to simian immunodeficiency virus does not prevent a subsequent rebound of viral replication, suggesting that viral reservoirs are established early. See Letter p.74

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Science 278, 1295–1300 (1997).

  2. 2.

    et al. Proc. Natl Acad. Sci. USA 94, 13193–13197 (1997).

  3. 3.

    et al. Nat. Med. 5, 512–517 (1999).

  4. 4.

    et al. Nature Med. 9, 727–728 (2003).

  5. 5.

    et al. Science 323, 1304–1307 (2009).

  6. 6.

    et al. Nature 512, 74–77 (2014).

  7. 7.

    et al. Proc. Natl Acad. Sci. USA 95, 8869–8873 (1998).

  8. 8.

    et al. J. Infect. Dis. 195, 1762–1764 (2007).

  9. 9.

    et al. J. Antimicrob. Chemother. 68, 1169–1178 (2013).

  10. 10.

    et al. PLoS ONE 7, e33948 (2012).

  11. 11.

    et al. Retrovirology 8, 97 (2011).

  12. 12.

    et al. PLoS Pathogens 9, e1003211 (2013).

  13. 13.

    et al. N. Engl. J. Med. 369, 1828–1835 (2013).

  14. 14.

    Nature (2014).

  15. 15.

    , , , & . Proc. Natl Acad. Sci. USA (2014)

  16. 16.

    et al. Nature 502, 100–104 (2013).

Download references

Author information

Affiliations

  1. Kai Deng and Robert F. Siliciano are in the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

    • Kai Deng
    •  & Robert F. Siliciano
  2. R.F.S. is also at the Howard Hughes Medical Institute, Baltimore.

    • Robert F. Siliciano

Authors

  1. Search for Kai Deng in:

  2. Search for Robert F. Siliciano in:

Corresponding author

Correspondence to Robert F. Siliciano.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nature13647

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing